首页> 外文期刊>Journal de pharmacie clinique =: International journal of clinical pharmacy >A method of therapeutic optimization of prescriptions in a geriatric rehabilitation care unit
【24h】

A method of therapeutic optimization of prescriptions in a geriatric rehabilitation care unit

机译:一种老年人康复护理单元中处方治疗优化的方法

获取原文
获取原文并翻译 | 示例
           

摘要

The elderly are more frequently exposed to polypharmacy and iatrogenic events, especially in this population, more sensitive to the drugs' effects (polypathology, polypharmacy). In a geriatric rehabilitation care unit where clinical pharmacy is developed (medication reconciliation), therapeutic optimization is based on Laroche list, on "AMI" criteria of the HAS and on STOPP/START list, which are used during medication review. Optimization is also based on implicit criteria and on complementarity between geriatric physicians and clinical pharmacists. The objective of this prospective descriptive study on 86 patients was to describe the therapeutic modifications and to analyze the follow-up of changes, one and three months after discharge from hospital. 275 treatments were stopped (62.9% without indication), 87 overdoses or under doses were revised, 55 with negative risk-benefit balance were stopped (20% of stopped treatments). One hundred and eleven START criteria were begun (316 treatments, 20% just for vitamin D) to fight against underuse. Explications of modifications in the medication were sent to general practitioners (GP) and community pharmacists to justify them at the end of the hospitalization. The remaining changes reached a rate of 77.9% and 71% respectively one and three months after discharge. Discontinuations of treatments initiated during hospital stay were maintained: 96% one month after discharge, 93,1% three months after.
机译:老年人更频繁地暴露于多酚和性能事件,特别是在这种人群中,对药物的影响更敏感(PolyPo病,PolyPharmacy)。在发育临床药房的Geriatric康复护理单元中(药物和解),治疗优化基于Laroche列表,在药物审查期间使用的“AMI”标准和STOPP /开始列表中的标准。优化也基于隐性标准和老年医师和临床药剂师之间的互补性。对86名患者的这项前瞻性描述性研究的目的是描述治疗修改,并分析从医院排放后的一个和三个月的变化的后续行动。停止了275例治疗(没有指示62.9%),修订了87次产量或剂量下,停止了55例,负性风险效益平衡(占停止治疗的20%)。开始标准(316种治疗,20%用于维生素D),以防止欠冰。药物治疗的筛选被送到一般从业者(GP)和社区药剂师,以便在住院期结束时证明他们。剩余的变化分别达到出院后一及三个月的77.9%和71%。在医院住院期间发起的治疗中的中断维持:排放后的96%,在三个月后为93,1%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号